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Abstract
Background: Gait function may be impaired in patients with vestibular disorders, making gait assessment in the
clinical setting relevant for this patient population. The purpose of this study was to evaluate the discriminant
validity of a gait assessment protocol between patients with vestibular disorders and healthy participants.
Furthermore, test re-test reproducibility and the measurement error of gait performance measures in patients
with vestibular lesions was performed under different walking conditions.
Methods: Gait parameters of thirty-five patients with vestibular disorders and twenty-seven healthy controls
were assessed twice with the GAITRite® system. Discriminant validity, reproducibility (intra class correlation [ICC]) and
the measurement error (standard error of measurement [SEM], smallest detectable change [SDC]) were determined for
gait speed, cadence and step length. Bland-Altman plots were made to assess systematic bias between tests.
Results: A significant effect of grouping on gait performance indicates discriminant validity of gait assessment. All tests
revealed differences between patients and healthy controls (p < 0.01). The ICCs for test re-test reproducibility were
excellent (0.70-0.96) and measurement error showed acceptable SDC values for gait parameters derived from three
walking conditions (9-19 %). Bland-Altman plots indicated no systematic bias.
Conclusions: Good validity and reproducibility of GAITRite® system measurements suggest that this system could
facilitate the study of gait in patients with vestibular disorders in clinical settings. The SDC values for gait are generally
small enough to detect changes after a rehabilitation program for patients with vestibular disorders.
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Background
Patients with vestibular disorders typically suffer from
vertigo, vision disorders, body imbalance and limitation
in mobility and the activities of daily living [1, 2]. Vertigo
symptoms are usually triggered by activities that require
head movements and transfers, or during walking [3, 4].
Furthermore, vestibular dysfunction is an important pre-
dictor for falls, especially in aging people [5]. The preva-
lence of dizziness and vertigo in Europe is 20—30 % in
adults, of which approx. 7.8 % are defined as having a
vestibular vertigo [6, 7].
The current management of vestibular disorders includes
vestibular rehabilitation, pharmacological treatment, sur-
gery, manual therapy and positioning manoeuvres for a
specific diagnostic group of benign paroxysmal positional
vertigo [8–10]. To date, there is moderate to strong evi-
dence for vestibular rehabilitation to be effective in the
management of unilateral peripheral vestibular dysfunction
for improving balance and walking skills [8].
Specific walking parameters of patients with vestibular
disorders need to be assessed for diagnosis and reassess-
ment after therapy. For this reason, valid and reliable in-
struments monitoring patients' gait are required. Gait
abnormalities may be assessed with the Functional Gait
Assessment (FGA), a 10-item assessment based on the
Dynamic Gait Index [11]. Although the FGA is a practical
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and functional assessment tool, it does not quantify tem-
poral and spatial gait parameters beyond a sum score.
Quantification of gait parameters while performing the
FGA would, however, add more sophisticated information
to a gait assessment.
Laboratory-based measurement instruments have been
developed to enable improvement of walking analyses and
to document diagnostic and therapeutic effectiveness. For
instance, the GAITRite® walkway analysis system was de-
veloped to measure temporal and spatial gait parameters
by using an approximate seven-metre walkway embedded
with pressure sensors. This provides objective, precise and
repeatable measurements in various clinical populations
[12, 13]. The GAITRite® walkway analysis system was used
in several studies and showed good validity and reliability
for measuring temporal and spatial gait parameters in
healthy adults [14]. Previous research tested the GAITRite®
system in young and elderly (healthy) participants and
patients with Parkinson's disease and stroke [13, 15, 16].
Schniepp, et al. [17] determined the variability of gait
parameters using the GAITRite® system in patients with
cerebellar ataxia, patients with vestibular disorders and
healthy participants. Self-selected walking speed for
healthy participants was 1.11 ± 0.19 m/s, for cerebral
ataxia 1.0 ± 0.2 m/s and for patients with bilateral ves-
tibular disorders 1.0 ± 0.2 m/s, indicating a difference of
approximately 10 % between healthy participants and
patients with vestibular disorders.
When a novel instrument is introduced for clinical use
in a patient population it is important to evaluate the
degree to which scores of different relevant groups de-
viate with a feasible measurement protocol [18]. Thus;
publication of study results will establish the stability of
an assessment. We hypothesised that gait assessed with
the GAITRite® system would reveal differences for self-
selected walking speed, cadence and step length be-
tween patients with vestibular disorders and healthy
age-matched adults [13].
Furthermore, to be clinically meaningful, the measure-
ment procedure also needs to be reliable in detecting
differences in outcomes after a therapeutic intervention
[19]. Reliability can be reported in terms of reproducibility
[20, 21], which indicates the degree of association between
two or more measures (e.g. Intraclass Correlation Coeffi-
cients [ICC]) [20], but does not provide clinical guidance
for assessing true changes in individuals [22, 23].
Several studies evaluated the psychometric properties of
the GAITRite® system and demonstrated good reproduci-
bility. Hollman, et al. [24] reported excellent ICCs for
velocity and cadence with ICC (2.1) values >0.84 in older
people under single and dual-task walking conditions.
In stroke patients, test re-test reproducibility measures
for the GAITRite® system were consistent with ICC (2.1)
values varying from 0.72 to 0.98 [16, 25].
Measurement error reflects the differences between
two measures [26]. Examples of these measures are the
standard error of measurement [SEM], calculated as the
square root of error variance and the smallest detectable
change [SDC] [27, 28]. To be clinically useful, measurement
error needs to be considered in relation to meaningful
change or clinically important differences [29].
In daily routine the assessment of gait patterns, with or
without additional motor or cognitive tasks (dual tasking,
such as counting backwards while walking or rotating the
head, while walking), are common in clinical practice,
e.g. diagnostic investigations in patients with vestibular
disorders [30–32]. These clinical protocols do not, however,
provide detailed information on changes in distinctive
aspects of gait parameters that have potential clinical
importance. Given the selective response of gait to path-
ology and evolution of disease, a more selective approach
that would allow the observation of important changes in
gait parameters is required [33]. Thus, when evaluating
the validity and reliability of a gait assessment protocol,
additional motor tasks should also be considered together
with techniques that allow more detailed parameters of
gait. Based on the FGA, a gait protocol was developed to
evaluate 7 of 10 FGA tasks with the GAITRite® system.
In this study, the hypothesis was tested if the GAITRite®
system could discriminate patients with vestibular disorders
from healthy participants for the outcomes of self-selected
walking speed, cadence and step length. Based on the study
of Menz, et al. [13], a magnitude of 10 % or larger differ-
ence in outcomes was defined. Further, patients were evalu-
ated twice to determine the test re-test reproducibility (ICC
2.1) and the measurement error (SEM, SDC) of walking be-
haviour as assessed with the GAITRite®. We conducted this
study to (a) investigate the degree to which the scores of a
gait analysis performed with the GAITRite® differ between
patients with vestibular disorders and healthy participants,
(b) identify the reproducibility of gait parameters measured
with GAITRite® in patients with vestibular disorders walk-
ing under single and dual-task conditions, and (c) identify
the measurement error (precision).
Methods
Design
A cross-sectional study design was chosen.
Patients and participants
The study sample included patients with vestibular disor-
ders and healthy control subjects. Patients with a diagnosis
of vestibular dysfunction undergoing neuro-otological in-
vestigation at the University Hospital Zurich, Switzerland
were recruited from the Departments of Neurology and
Otorhinolaryngology at the Hospital. The vestibular test-
ing battery of patients included three-dimensional video
or search-coil head impulse testing along all 6 semicircular
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canals, caloric warm and cold water testing of both ears,
subjective visual vertical, as well as ocular and cervical ves-
tibular evoked myogenic potentials. For the purpose of
this study, however, the definition of a vestibular deficit re-
lied only on the functions of the horizontal semicircular
canals, as assessed with horizontal head impulse testing to
both sides (video or search coil system) [34–36] and cal-
oric irrigation (video-oculography) [37]. Healthy subjects
were recruited by personal invitation, e-mail and flyer
from the staff of the University Hospital Zurich and from
community dwellers in the greater area of Zurich. To be
included in the study, participants were required to be aged
over 18 years, subjects from the patient group needed to be
diagnosed with a vestibular disorder. The following partici-
pants were excluded: after successful re-positioning ma-
noeuvres compensating the vertigo symptoms, if they were
not able to walk ten meters independently, had acute pain,
uncontrolled cardiovascular disease, hip or knee endo-
prosthesis, weakness due to neurological problems, or
being known as or suspected of being non-compliant.
All study participants were in a physically stable condi-
tion and provided written informed consent. The ethics
committee of Canton Zurich, Switzerland, approved the
study (Ref. Nr. EK: KEK-ZH-Nr. 2013-0286).
Instrumentation: GAITRite® system
In order to assess temporal and spatial gait characteristics,
the GAITRite® walkway analysis system (CIR Systems, Inc.,
Corporate Headquarters 376 Lafayette Ave. Suite 202,
Sparta, NJ 0787) was used. It consists of a roll-up walkway
(approximately seven meters long) with 13824 pressure
sensors embedded in an active area of 366x61 cm, arranged
in a grid-like pattern. Data were uploaded to a computer
and automatic footstep identification took place. The
system directly supplies clinicians and researchers with
quantitative information about a subjects’ gait.
Procedure
Subjects' characteristics, such as gender, age, height, weight,
diagnosis, and Functional Gait Assessment (FGA) [11]
score, were recorded. After informing and instructing the
study participants about the measurement procedure, all
participants completed one test to get them familiar with
the setting and the GAITRite® system. Participants were ad-
vised to perform the measurement sessions wearing com-
fortable flat walking shoes and the same shoes were to be
used for both measurements. The GAITRite® mat was posi-
tioned in a long and well-lit corridor. In order to assess the
steady state of walking and to avoid recording the acceler-
ation and deceleration phases, two meters of additional
walking space before and after the mat allowed each
participant room for starting and ending each walking trial
[14, 38]. The patients and healthy subjects performed one
walking trial for 7 protocol walking conditions. The same
tester conducted all tests, operated the GAITRite® system
and walked next to the participants to guarantee safety
during the test.
The participants completed seven trials on the GAITRite®
walkway following a predefined gait protocol. Prior to the
trials, participants were given standardised instructions and
a visual demonstration. The gait protocol was performed at
a self-selected preferred walking speed and consisted of six
tasks derived from the FGA in a non-random order [11]
and with an additional cognitive task added to some of the
walking trials.
The gait protocol included the following tasks of the
FGA: [1] self-selected walking speed without dual task,
[2] gait with horizontal head turns, [3] gait with vertical
head turns, [4] gait with narrow base of support (with
tandem steps), [5] gait with closed eyes and [6] walking
backwards. In addition we tested gait with a dual tasking
paradigm (counting backwards in steps of 7 from 100
during self-selected walking speed [39]). The latter task
was added as we expected differences in temporal and
spatial gait parameters between patients and healthy par-
ticipants [40]. The FGA tests Change in gait speed, Gait
and pivot turn, Step over obstacle and Steps on stairs
where not recorded, as it was deemed not feasible or
useful to be measured with the GAITRite® system.
Patients with vestibular disorders repeated the gait
protocol after a ten-minute interval in order to assess
the discriminant validity, the test re-test reproducibility
and the measurement error. The following three tem-
poral and spatial gait measurements were evaluated: Gait
speed (m/s), cadence (steps/min.) and step length (cm).
These outcome parameters were selected as they reflect
disturbances in gait in patients with vestibular disorders
[41]. The locomotion pattern of vestibular patients can,
furthermore, be described with these three parameters
[42]. These parameters are also sensitive to change and
they improve after vestibular rehabilitation [3].
Data processing
The recorded measurements were analysed immediately
after each walking attempt on the GAITRite® system.
Footsteps, which did not fit completely within the
active area of the GAITRite® system, were removed manu-
ally from the recorded walk. Mean values for each gait
parameter were calculated. Further, in order to minimise
environmental variability walking evaluations were con-
ducted in the same hallway for each test.
Statistics
Patients’ characteristics are described in Table 1. For hy-
pothesis testing of the discriminative validity, unpaired t-
tests were performed to determine the mean difference in
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measurements for gait variables in healthy subjects and
patients with vestibular disorders.
ICC (2.1) was used to determine test-retest reproduci-
bility. For the interpretation of ICC values, benchmarks
were used as described by Fleiss, Levin, and Paik [43]
(>0.75 excellent, 0.40-0.75 fair-to-good, and <0.40 poor
reliability). Since ICC only provides information about
the reproducibility, the smallest detectable change [SDC]
was additionally calculated at the 95 % confidence level
using: SDC ¼ 1:96  SEM  ﬃﬃﬃ2p [22]. The SEM was
determined using SEM ¼ SD  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 ‐ ICCp [29, 44].
The SEM% as percentage of the mean (mean for the
observations from test session 1 and 2) was defined by:
SEM% = SEM/mean*100. The SDC% was calculated as
the SDC divided by the mean for all measurements and
multiplied by 100 % to be independent of the units of
measurement [45]. The SDC% is a type of relative index
and represents the limit for the smallest change that indi-
cates a real change. A good measurement tool preferably
shows low SEM and SDC values to be able to detect
changes in a clinical trial [29].
Finally, systematic bias was assessed with the Bland-
Altman analyses [46]. The Bland-Altman plot provides
visual information in which the individual differences
between the two measurements were plotted adverse to
the individual means. The graph permitted the appraisal
of the data regarding heteroscedasticity and detection of
the minimal detectable change, which exceeds the meas-
urement error in repeated measures [47].
Analyses were performed using SPSS Version 22.0
statistical software (SPSS, Inc. Chicago, IL) and level of
significance was set at 5 %.
Results
Thirty-nine outpatients were initially invited to participate
in the study; four of these patients were subsequently ex-
cluded. Two patients were excluded due to being diag-
nosed with a benign paroxysmal positional vertigo, and
diminished vertigo symptoms after treatment, one patient
was excluded as he was younger than 18 years old and one
patient was excluded due to the diagnosis of vestibular
disorder not being able to be confirmed. The remaining
35 patients (21 men/14 women, mean age 59 ± 17 years,
age range 18—86 years) were diagnosed with several ves-
tibular disorders (bilateral peripheral vestibular dysfunc-
tion, unilateral peripheral vestibular dysfunction, central
vestibular dysfunction, Menière’s disease, and vestibular
migraine). The control group of 27 healthy adults (mean
age 44 ± 12.7 years) consisted of 14 men and 13 women
(Table 1).
For the parameter tandem walking, the GAITRite®
software had considerable difficulty automatically detect-
ing footfalls. Stolze, et al. [48] demonstrated that tandem
walking in neurological patients consists of short and long
steps, crossing of the legs and deviations of the foot from
the ideal pathway. As missteps could not be recorded opti-
mally with the GAITRite® system, tandem walking is not
recommended as a valid test for assessing patients with
vestibular dysfunction using the GAITRite® system. Thus,
human intervention was required to process the data from
two footfalls to one. As this is clinically not feasible, the
measurements were declared invalid and not presented in
the manuscript and tables.
The measurements of three patients yielded invalid
values for negative step length and could not be used for
the reproducibility analysis. Therefore, the analyses of 32
patients were performed for self-selected walking speed
(see Table 3). Furthermore, for discriminant validity and
reproducibility, one patient could not perform the task
‘walking under dual-task conditions, as he was afraid to
loose balance or fall. These analyses were, therefore, per-
formed with 34 patients (Tables 2 and 3).
Hypothesis testing for discriminant validity of the
GAITRite® walkway
Data for temporal and spatial gait parameters (gait speed,
cadence and step length) and the specific walking condi-
tions are presented in Table 2. For patients with vestibular
disorders, the values in the 6 different walking tasks for
gait speed varied from 0.7 to 1.2 m/s, for cadence from
88 to 108 steps/min. and for step length from 40 to 64 cm.
See Table 2 for the mean values across all walking tasks.
Data for gait speed varied for healthy control subjects
Table 1 Subjects’ characteristics reported as mean values ± SD
Healthy Patients
(n = 27) (n = 35)
Female 13 14
Male 14 21
Age; years (SD) 44 (13) 59 (18)
Age range; years 25/70 18/86
Weight; kg (SD) 63 (21) 74 (15)
Height; cm (SD) 160 (47) 169 (9)
Score Funtional Gait Analyses SD)a - 22 (6)
FGA range - 3/30
- Bilateral peripheral vestibular dysfunction score - 14
- Unilateral peripheral vestibular dysfunction - 9
- Central vestibular dysfunction - 6
- Morbus Menière - 5
- vestibular migraine - 1
aA cutoff score of 22/30 on the FGA provides optimum validity for classifying
fall risk in older adults at risk for falling and in predicting unexplained falls
in community-dwelling older adults. The FGA appears to predict falls in
community-dwelling older adults better than the currently recommended
clinical tools (e.g. Berg Balance Scale and the Timed Up and Go Test). This
22 from 30-possible-points cutoff score may be used as indicator for falls in
elderly patients with vestibular dysfunctions [57]
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Table 2 Discriminative validity between patients (n = 35) with vestibular disorders and healthy participants (n = 27) (determined by an unpaired t-test, level of significance
at p≤ 0.05)
Gait speed (m/s) Cadence (steps/min.) Step length (cm)
Gait tasks with; Mean patient
(SD)
Mean healthy
(SD)
p Mean Difference
(CI)
Mean patient
(SD)
Mean healthy
(SD)
p Mean Difference
(CI)
Mean patient
(SD)
Mean healthy
(SD)
p Mean Difference
(CI)
Self-selected walking
speed
1.2 (0.2) 1.4 (0.2) <0.001 0.3 (0.2/0.4) 108.0 (10.4) 115.7 (8.0) 0.002 7.8 (3.0/12.6) 64.0 (9.9) 73.6 (9.4) <0.001 10.0 (4.9/15.0)
Horizontal head turns 1.0 (0.2) 1.3 (0.2) <0.001 0.3 (0.1/0.4) 98.8 (14.3) 107.2 (9.5) 0.010 8.5 (2.1/14.8) 60.8 (9.1) 71.2 (8.7) <0.001 10.6 (5.9/15.4)
Vertical head turns 1.0 (0.3) 1.3 (0.2) <0.001 0.3 (0.2/0.4) 99.5 (15.9) 109.8 (9.9) 0.004 10.3 (3.4/17.3) 60.0 (11.2) 71.6 (8.9) <0.001 12.2 (6.7/17.6)
Closed eyes 0.8 (0.2) 1.2 (0.3) <0.001 0.4 (0.2/0.5) 97.9 (15.0) 108.5 (13.6) 0.005 10.6 (3.3/18.0) 48.8 (11.8) 65.0 (10.6) <0.001 15.0 (8.6/21.4)
Ambulating
backwards
0.7 (0.2) 1.0 (0.2) <0.001 0.3 (0.2/0.4) 95.8 (14.3) 105.1 (12.8) 0.010 9.2 (2.3/16.3) 40.8 (9.3) 54.4 (8.7) <0.001 12.8 (8.2/17.4)
Dual taska 0.9 (0.2) 1.2 (0.3) <0.001 0.3 (0.2/0.4) 88.3 (16.1) 101.8 (17.3) 0.005 11.4 (0.2/0.4) 58.8 (9.1) 68.4 (10.2) 0.001 8.8 (3.7/13.8)
aDual tasking for Gait speed, Cadence and Step length was performed with n = 34a patients. The dual-tasking paradigm was performed with a) self-selected walking speed and b) dual-tasking (counting backwards from
100 in steps of 7 during self-selected walking speed
Schm
idheiny
et
al.BM
C
Ear,N
ose
and
Throat
D
isorders
 (2015) 15:6 
Page
5
of
10
from 1.0 to 1.4 m/s, for cadence from 101 to 115 steps/
min. and for step length from 54 to 73 cm. All tests
showed significant differences between the two groups
(p ≤ 0.01) with differences generally above 10 % between
patients and healthy participants for self-selected gait
speed and step length. Patients with vestibular disorders
walked more slowly in all test conditions with a lower
cadence and a shorter step length compared to healthy
controls.
Reproducibility
Test re-test reproducibility of the walking tasks ranged
with ICCs from 0.70 to 0.96 in patients with vestibular
disorders. The range for the SEM for each gait condition
varied from 2.5-9.0 %. The range for the SDC for all
conditions was for the gait speed 0.14 to 0.26 m/s, for
the cadence 9 to 24 steps/min. and step length from 6.4
to 9.6 cm (see Table 3). Most of the data were between 2
standard deviations in the Bland-Altman plots, with the
exception of a few outliers (1-2) in gait speed and cadence
for self-selected walking speed. The Bland and Altman
plots for step length yielded 4 data points outside the 2
standard deviations. The Bland-Altman plots for gait
speed, cadence and step length of the task self-selected
walking speed for patients are illustrated in Fig. 1. The
negative gait speed value of the mean difference line in
the Bland-Altman plot indicates that the first walking
attempt was generally slower than the second walking
attempt. Lower cadence, as well as smaller step length
values, were reported in the first walking session compared
to the second (Fig. 1). Visual inspection showed no ten-
dency towards heteroscedasticity.
Discussion
The aim of this study was to evaluate the discriminant
validity and re-test reproducibility of a walking assessment
protocol measuring spatial and temporal gait parameters
during different walking conditions and performed on the
GAITRite® walkway analysis system.
The results of this study suggest that the walking as-
sessment protocol performed on the GAITRite® system
yields good discriminant validity between patients with
vestibular disorders and healthy participants. Further-
more, excellent test re-test reproducibility values were
determined for gait speed, cadence and step length mea-
sured under different walking conditions in patients with
vestibular dysfunction.
Discriminant validity
In this study, an approximate 10 % difference between
patients and healthy controls in favour of healthy controls
was observed in normal walking for the mean values of the
parameters gait speed, cadence and step length. Differences
for GAITRite® parameters between patients and healthy
participants with a comparable magnitude were also mea-
sured in a report on individuals with cerebellar ataxia [48],
patients with unilateral peripheral vestibular loss [UVL]
and patients with bilateral peripheral vestibular loss [BVL]
[41]. The small sample size and the heterogeneity of
our sample (central vestibular dysfunction, M. Menière,
and vestibular migraine) may have led to these differences.
Conversely, other studies did not show significant dif-
ference for the parameters gait speed and cadence of
self-selected walking between BVL patients and healthy
controls [14, 17, 49]. However, the differences between
groups in this study are supported by small SDC values
Table 3 Reproduciblity and measurement error: ICC, SEM and SDC for patients with vestibular disorders (n = 35)
Gait speed (m/s) Cadence (steps/min.) Step length (cm)
Gait tasks with; ICC (CI) SEM SDC ICC (CI) SEM SDC ICC (CI) SEM SDC
Self-selected walking speed 0.94 0.05 0.15 0.87 3.5 10.0 0.95b 2.2b 6.1b
(0.89/0.97) (0.76/0.94) (0.91/0.98)
Horizontal head turns 0.93 0.07 0.20 0.70 9.0 24.9 0.93 2.5 7.0
(0.86/0.96) (0.49/0.84) (0.86/0.96)
Vertical head turns 0.96 0.06 0.16 0.85 6.2 17.1 0.96 2.3 6.4
(0.92/0.98) (0.72/0.93) (0.93/0.98)
Closed eyes 0.87 0.08 0.23 0.83 6.3 17.3 0.92 3.4 9.4
(0.78/0.94) (0.70/0.92) (0.85/0.96)
Ambulating backwards 0.95 0.09 0.26 0.94 3.4 9.5 0.95 2.5 6.9
(0.90/0.98) (0.88/0.97) (0.91/0.98)
Dual taska 0.89 0.05 0.14 0.89a 5.6 15.5 0.87 3.4 9.6
(0.79/0.95) (0.79/0.94) (0.75/0.93)
aDual tasking tests were performed with 34 patients; bStep length during self-selected walking speed was performed in 32 patients. Three measures were invalid
and could not be repeated. The dual-tasking paradigm was performed with a) self-selected walking speed and b) dual-tasking (counting backwards from 100 in
steps of 7 during self-selected walking speed
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that were smaller than the differences found between
patients and healthy adults, thus indicating good dis-
criminant validity of the protocol.
Reproducibility and measurement error
The excellent ICC values found in this study are com-
parable with those of studies evaluating ICC in healthy
elderly people [13, 14, 24], patients with a degenerative
neurological disorder [50] and stroke patients [16, 25].
An improvement in gait parameters for patients with
vestibular dysfunction after therapy can only be mea-
sured when the measurement error of the instrument is
small enough to detect a real change [22]. A recently
published review [3] described a clinical gait speed im-
provement of 0.2 m/s after vestibular rehabilitation in
patients with UVL. Thus, the SDC values for self-selected
walking found in this study were lower than those that
might be expected following rehabilitation as revealed by
Herdman [3]. To the best of our knowledge, comparable
data are only available for the parameter gait speed in self-
selected walking when determining the improvement on an
individual patient level [3]. Parameters of measurement
error will be more stable over different population samples
than reproducibility parameters. Reproducibility parameters
are highly dependent on the variation in the population
sample and are only generalizable with samples of a similar
variation. It is clearly a characteristic of the performance of
an instrument in a certain group sample. Measurement
error is more a characteristic of the measurement instru-
ment itself. Measurement error parameters are preferable
in all situations in which the instrument is used for evalu-
ation purposes, which is often the case in medical research
in a clinical setting. Researchers and clinicians should
be eager to apply and interpret the parameters of meas-
urement error (on an individual level) and reproducibility
(on a group level) correctly [22].
To be of practical use, the results of the SDD should
be interpreted as follows: when taking the measurement
error into account, an SDC equal to or greater than
0.05 m/s (Table 3) between two measurements should
be used as the threshold for a true clinical change in
self-selected walking. In the Bland and Altman Plot for
self-selected walking speed, the midline showed a mean
difference between assessments of -0.03 m/s with a lower
limit of (95 % agreement) of -0.18 and upper limit of
agreement of 0.11 m/s, indicating that the patients walked
slower in the re-test. The result of the other assessments
in the reproducibility study should be interpreted in the
same way (see Table 3, and Fig. 1 (self-selected walking
with dual task).
The Bland-Altman plots showed a small systematic
error between test and re-test (-0.03 m/s), albeit this dif-
ference did not reach significance. Therefore, it may be
that patients became accustomed to the GAITRite® walk-
ing system and increased speed in their second attempt.
Hamacher, et al. [51] recommended the application of a
defined amount (familiarisation) of cycles to determine
reliable measures of variability. The use of only one gait
attempt that we used to familiarise the patients with the
measurement set-up may influence the precision of vari-
ability measures. Although a familiarisation session was
performed as previously proposed [52], the patients may
have walked more confidently during the second test
session. Training effects may explain the increase in gait
Fig. 1 Bland-Altman plots for self-selected walking speed (left) and walking with dual task (right). Difference in individual self-selected gait speed
between the test re-test sessions, plotted against the individual mean gait speed of the two sessions (m/s). The plot on the left side demonstrates
self-selected walking, the plot on the right side self-selected walking speed with performance of a concurrent cognitive dual task. The mid line
shows the mean difference (-0.03 m/s left and -0.04 m/s right), dashed lines show the upper and lower limits of (95 %) agreement (-0.18 and 0.11 m/s
left and -0.27 and 0.19 m/s right)
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speed during the second attempt [53] and the absence of
severe vertigo symptoms in the participants. In order to
minimize such a training effect and considering the
time-restraints for assessments in the clinical setting we
opted to conduct one test trial.
Further research should obtain comparable data for other
gait parameters (cadence and step length) and in other
walking conditions. Overall, the measurement protocol
performed on the GAITRite® system indicates good re-
producibility in patients with vestibular deficits and can,
therefore, be recommended as a feasible assessment tool
in the clinical setting.
Different walking conditions
Walking speed decreased in patients with vestibular dys-
function while performing a dual task. Dual tasking also
resulted in larger gait speed SDC values (23 to 26 %). It
may be assumed that the task used in our study (counting
backwards in steps of seven) affected the absolute reliability
of gait speed more than a simple task would have, such as
counting backwards in steps of two [49].
Study limitations
This study has some limitations.
Firstly, the lack of a standardised measurement proto-
col for the GAITRite® system limits the interpretation of
gait variability from evaluative and prognostic studies. The
differences found in our study between patients with
vestibular disorders and healthy subjects does not in it-
self prove validity for the GAITRite® system, it rather
contributes to the evidence for or against validity which
is an ongoing process. Further research is needed to
standardise testing procedures and establish validity, re-
producibility and measurement error for confident use
of GAITRite® walking system in patients with vestibular
disorders.
Secondly, the sample size was relatively small and may
have affected the values of the reproducibility and measure-
ment error. A sample size of at least 50 is generally seen as
adequate for the assessment of the agreement parameter,
based on a general guideline by Altman (1990) [54]. The
sample size of 35 patients with vestibular disorders we used
and 27 controls is, however, a realistic group size to find
first estimates for the assumed relation between vestibular
disorders and gait and to identify differences between
patients and healthy controls.
Thirdly, the majority of vestibular patients reported that
they did not have acute symptoms at the time of the test.
Due to the chronic nature of vestibular disorders, most
patients may have compensated their vestibular deficiency,
e.g. by exaggerated hip sway in order to enhance balance
or by looking down at the floor to avoid dizziness. This
possibly influences the test. Furthermore, the group of
healthy control subjects was younger than the group of
patients with vestibular dysfunctions. Thus, the difference
in gait speed found between patients and controls could
depend on age in addition to the vestibular deficit [55].
Fourthly, the fact that we measured one walking trial
per protocol walking condition may be regarded as an
additional limitation. The amount of analysable gait cycles
is limited because of this procedure and, in turn, influ-
ences the specificity of the gait measures [51]. However
when using pressure walkways, stop and go movements
introduce transients in the stride trajectories that have the
potential to bias variability in terms of reproducibility and
measurement error [51]. Conversely, in a clinical setting
time and resource constraints often prevent performance
of extensive measurement protocols. Furthermore, our
patients performed their measures during clinical visits
to the University Hospital and we did not want to daunt
them with a stressful program.
Fifthly, the short time break of 10 min between measure-
ments could influence the reproducibility and measurement
error data in this study. However, one study reported good
to excellent ICC’s (0.87-.097) for self-selected walking
speed, cadence and step length and SEM’s with a 15-min
break between measures [56]. Furthermore, the internal
consistency of the FGA as determined with Cronbach alpha
is with 0.79 [11] good, which further indicates that no be-
havioural response in gait is to be expected when gait is
measured. Currently, there is no standardisation for an op-
timal time break between reproducibility measures. Thus,
researchers and clinicians have to choose an optimal time
frame when designing a study.
Despite these caveats, we believe that our study provides
useful results regarding the reproducibility and measure-
ment error measured with the 6 walking-conditions test
performed on the GAITRite® system in patients with ves-
tibular disorders. This documents the sustained deficit in
gait patterns experienced by these patients when compared
to healthy controls.
Conclusions
The results of this study demonstrate that our walking
protocol performed on the GAITRite® walkway analysis
system results in valid and reproducible spatial and tem-
poral gait parameters in patients with vestibular disorders.
The addition of the GAITRite® system to clinical assess-
ment protocols may determine a real change in gait speed,
cadence and step length. The GAITRite® system may be
employed in studies and clinical settings to determine the
effect of disease outbreak and exercise in rehabilitation
programs.
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